Cajal Neuroscience
cajalneuro.comLocations
Seattle, WA, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Series A
founded in
2020
Cajal Neuroscience is a drug discovery company focused on neurodegenerative diseases, utilizing high-throughput microscopy, functional genomics, and multi-omics analyses to identify new drug targets and therapeutics. The company aims to generate novel disease-altering therapies, leveraging a passionate team of scientists and advanced technologies to position itself as a leader in the neurodegeneration market. With a commitment to innovation and scientific excellence, Cajal Neuroscience is poised to make significant contributions to the treatment of conditions like Alzheimer's and Parkinson's disease.
Something looks off?Open jobs at Cajal Neuroscience
On-site & Remote
Job function
Seniority
Salary